Joshua Levine, Director at EDAP TMS SA (EDAP), bought 10,000 shares at $4.75 ($48K) on 2026-08-14, disclosed to the SEC on 2026-08-17.
Director Joshua Levine purchased $47,500 of EDAP stock at $4.75, marking the largest insider purchase in the company's history. This significant buy signals confidence in the company's strategic pivot and recent operational momentum.
The stock is trading near its 52-week low, currently down 5.28% from the high of $4.45 and down 4.2% over the last 90 days.
1) Upcoming FocalTherics Investor Day on June 1, 2026, where management will outline a shift toward high-growth, pure-play robotic focal therapy. 2) The company reported 39% revenue growth in its core HIFU business in 2025, with record commercial performance for Focal One.
The stock is trading at a significant discount to its 52-week high, down 5.28% from the high of $4.45, indicating potential overhang or undervaluation concerns.
Something here stands out, but not much.
| Filing → |
| ARAY | BUY | 2021-08-19 | $54K | — | Filing → |
| ARAY | SELL | 2020-12-02 | $128K | — | Filing → |
| ARAY | SELL | 2020-10-06 | $37K | — | Filing → |